Lee's Pharmaceutical Holdings Limited — Proxy Solicitation & Information Statement 2021

Feb 24, 2021

==> picture [95 x 42] intentionally omitted <==

Lee’s Pharmaceutical Holdings Limited 李氏大藥廠控股有限公司[*]

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 950)

PROXY FORM FOR USE BY SHAREHOLDERS AT THE EXTRAORDINARY GENERAL MEETING

I/We [(Note][1)] of (Address) being the registered holder(s) of [(Note][2)] shares (“ Shares ”) of HK$0.05 each of Lee’s Pharmaceutical Holdings Limited (“ Company ”) hereby appoint the chairman of the meeting or (Note 3) of

(Address) to act as my/our proxy at the meeting to be held at 1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin, New Territories, Hong Kong on Monday, 15 March 2021 at 3:00 p.m. and at any adjournment thereof and to vote on my/our behalf as directed below. I/We direct that my/our vote(s) be cast on the specified resolutions as indicated by an “✔” in the appropriated boxes. In absence of any indication, the proxy may vote for or against the resolution at his/her own discretion.

Please make a mark in the appropriate boxes to indicate how you wish your vote(s) to be cast on a poll [(Note][4)] .

		Resolutions For Against To approve the spin-off of Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology”), currently an associated company of the Company, and a separate listing of the new shares of Zhaoke Ophthalmology on The Stock Exchange of Hong Kong Limited (the “Proposed Spin-off”); and To authorise the directors of the Company, for and on behalf of the Company, to take all steps and do all acts and things as they consider to be necessary, appropriate or expedient in connection with and to implement or give effect to the Proposed Spin-off and to execute all such other documents, instruments and agreements (including the affixation of the Company’s common seal) deemed by them to be incidental to, ancillary to or in connection with the Proposed Spin-off. Shareholder’s signature: (Notes 5, 6, 7 and 8)
	1.
	2.
	Date:	Shareholder’s signature:

Notes:

1. Full name(s) and address(es) are to be inserted in BLOCK CAPITALS as shown in the register of members of the Company.

2. Please insert the number of shares registered in your name(s). If no number is inserted, this proxy form will be deemed to relate to all the shares in the capital of the Company registered in your name(s).

3. If any proxy other than the chairman of the meeting is preferred, strike out “the chairman of the meeting or” and insert the name and address of the proxy desired in the space provided. If no name is inserted, the chairman of the meeting will act as your proxy. A shareholder may appoint one or more proxies to attend the meeting and vote for him. The proxy need not be a member of the Company but must attend the meeting in person to represent you. Any alteration made to this form must be initialed by the person who signs it.

4. IMPORTANT: If you wish to vote for any of the resolutions set out above, please tick (“ ✔ ”) the boxes marked “For”. If you wish to vote against any resolutions, please tick (“ ✔ ”) the boxes marked “Against”. If the form returned is duly signed but without specific direction on any of the proposed resolutions, the proxy will vote or abstain at his discretion in respect of all resolutions; on any resolution properly put to the meeting other than those referred to in the notice convening the meeting or if in respect of a particular proposed resolution there is no specific direction, the proxy will, in relation to that particular proposed resolution, vote or abstain at his discretion. A proxy will also be entitled to vote at his discretion on any resolution properly put to the meeting other than those set out in the notice convening the meeting.

5. In the case of a joint holding, this proxy form may be signed by any joint holder, but if more than one joint holders are present at the meeting, whether in person or by proxy, that one of the joint holders whose name stands first on the register of members of the Company in respect of the relevant joint holding shall alone be entitled to vote in respect thereof.

6. The proxy form must be signed by a shareholder, or his attorney duly authorised in writing, or if the shareholder is a corporation, either under its common seal or under the hand of an officer or attorney so authorised.

7. To be valid, this proxy form together with any power of attorney or other authority (if any) under which it is signed or a notarially certified copy of such power or authority must be deposited at the offices of the Company’s Hong Kong share registrar, Computershare Hong Kong Investor Services Limited at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong not later than 48 hours before the time of the meeting or any adjournment thereof.

8. Completion and return of this proxy form will not preclude you from attending and voting in person at the meeting or any adjournment thereof if you wish to do so. In that event, this proxy form will be deemed to have been revoked.

PERSONAL INFORMATION COLLECTION STATEMENT

“Personal Data” in this proxy form has the same meaning as “personal data” in the Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Kong) (“ PDPO ”), which may include your and/ or your proxy’s name and address.

Your and your proxy’s Personal Data provided in this form will be used in connection with processing your request for the appointment of a proxy to attend, act and vote on your behalf as directed above at the Meeting. Your supply of your and your proxy’s Personal Data is on voluntary basis. However, the Company may not be able to process your request unless you provide us with such Personal Data.

Your and your proxy’s Personal Data will be disclosed or transferred to the Company’s branch registrar and transfer office in Hong Kong and/or other companies or bodies for the purpose stated above, or when it is required to do so by law, for example, in response to a court order or a law enforcement agency’s request, and will be retained for such period as may be necessary for the Company’s verification and record purpose.

By providing your proxy’s Personal Data in this form, you should have obtained the express consent (which has not been withdrawn in writing) from your proxy in using his/her Personal Data provided in this form and that you have informed your proxy of the purpose for and the manner in which his/her data may be used.

You/your proxy have/has the right to request access to and/or correction of your/your proxy’s Personal Data respectively in accordance with the provisions of the PDPO. Any such request for access to and/or correction of your/your proxy’s Personal Data should be in writing by mail to the offices of the Company’s Hong Kong share registrar, Computershare Hong Kong Investor Services Limited at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong.

• For identification purpose only